MANAGING YOUR GLAUCOMA

MAY BE EASIER THAN YOU IMAGINED

The Hydrus Microstent is a revolutionary therapy used to help manage your glaucoma. It has been proven in global clinical trials to lower eye pressure, which resulted in a reduction of glaucoma medicine and, in some patients, eliminated the need for medication.1

If you have primary open-angle glaucoma, ask your doctor if the Hydrus Microstent is right for you.

As a second-generation Minimally Invasive Glaucoma Surgery (MIGS) device, Hydrus is designed to decrease your eye pressure and reduce or eliminate your need for glaucoma medications. The Hydrus Microstent can be implanted at the time of cataract surgery or as a stand-alone therapy.

Data from the HORIZON Study (in combination with cataract surgery) shows:

77% of Hydrus Microstent patients saw a significant reduction in eye pressure1

78% of all patients with a Hydrus Microstent were drop free at 2 years1

Talk to your doctor to see if the Hydrus Microstent is right for you.

Please Select Your Country

Continue